Jazz Pharmaceuticals plc
JAZZ
$229.63
$0.440.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.49M | -356.11M | -368.44M | -404.80M | 482.24M |
| Total Depreciation and Amortization | 712.82M | 696.22M | 685.47M | 672.46M | 661.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 872.98M | 996.88M | 1.06B | 1.19B | 260.08M |
| Change in Net Operating Assets | -281.11M | 18.80M | 11.60M | -145.63M | 154.68M |
| Cash from Operations | 1.33B | 1.36B | 1.39B | 1.32B | 1.56B |
| Capital Expenditure | -64.57M | -58.77M | -55.33M | -50.94M | -45.07M |
| Sale of Property, Plant, and Equipment | 28.17M | 28.17M | -- | -- | -- |
| Cash Acquisitions | -858.05M | -858.05M | -858.05M | -858.05M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -323.43M | -621.33M | -417.73M | 119.78M | -360.23M |
| Cash from Investing | -1.22B | -1.51B | -1.33B | -789.22M | -405.29M |
| Total Debt Issued | -- | -- | 0.00 | 980.77M | 980.77M |
| Total Debt Repaid | -31.05M | -781.05M | -781.05M | -1.36B | -1.36B |
| Issuance of Common Stock | 129.32M | 107.92M | 31.93M | 31.21M | 31.65M |
| Repurchase of Common Stock | -236.68M | -200.28M | -202.29M | -350.08M | -387.09M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -5.72M | -5.72M | -5.72M |
| Cash from Financing | -138.41M | -873.41M | -957.13M | -699.87M | -736.43M |
| Foreign Exchange rate Adjustments | 4.46M | 6.56M | 4.24M | 7.11M | 1.72M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.65M | -1.02B | -892.15M | -166.00M | 418.48M |